Spinocerebellar ataxia type 13
=Spinocerebellar Ataxia Type 13 =
Spinocerebellar Ataxia Type 13 (SCA13) is a rare, genetic neurodegenerative disorder characterized by progressive problems with movement. It is one of the many types of spinocerebellar ataxia, which are a group of hereditary ataxias that often lead to poor coordination and balance.
Genetics[edit | edit source]
SCA13 is caused by mutations in the KCNC3 gene, which encodes the Kv3.3 voltage-gated potassium channel. This channel is crucial for the proper functioning of neurons, particularly in the cerebellum, which is the part of the brain responsible for coordinating movement.
Inheritance[edit | edit source]
SCA13 is inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene from an affected parent can cause the disorder in the offspring. This pattern of inheritance implies that each child of an affected parent has a 50% chance of inheriting the mutation.
Symptoms[edit | edit source]
The symptoms of SCA13 can vary widely among individuals, even within the same family. Common symptoms include:
- Ataxia, or lack of voluntary coordination of muscle movements
- Dysarthria, or difficulty with speech
- Nystagmus, or involuntary eye movements
- Cognitive impairments in some cases
The age of onset can also vary, with some individuals showing symptoms in childhood and others not until adulthood.
Diagnosis[edit | edit source]
Diagnosis of SCA13 typically involves a combination of clinical evaluation, family history, and genetic testing. Genetic testing can confirm the presence of mutations in the KCNC3 gene.
Treatment[edit | edit source]
Currently, there is no cure for SCA13. Treatment focuses on managing symptoms and improving quality of life. This may include:
- Physical therapy to improve coordination and balance
- Speech therapy for dysarthria
- Occupational therapy to assist with daily activities
Research[edit | edit source]
Research into SCA13 is ongoing, with studies focusing on understanding the disease mechanisms and developing potential therapies. Advances in genetic research and neurobiology hold promise for future treatments.
See Also[edit | edit source]
External Links[edit | edit source]
NIH genetic and rare disease info[edit source]
Spinocerebellar ataxia type 13 is a rare disease.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
